The etiologic spectrum of constrictive pericarditis

Cameron, James; Oesterle, Stephen N.; Baldwin, John C.; Hancock, E. William

doi:10.1016/0002-8703(87)90278-x

Cited by 221 publications

(109 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…CP is the result of scarring and loss of elasticity of the pericardial sac which restricts cardiac filling. Tuberculosis, cardiac surgery, radiation therapy, and connective tissue disorders are among common causes, however most of the cases are idiopathic or viral [179][180][181] . Patients with CP may present with symptoms of fluid overload such as edema and ascites, or symptoms of diminished cardiac output like exertional dyspnea and fatigue.…”

Section: Constrictive Pericarditis (Cp)mentioning

confidence: 99%

Hepatic venous outflow obstruction: Three similar syndromes

Bayraktar

Seren²,

Bayraktar³

2007

WJG

116

110

View full text Add to dashboard Cite

Our goal is to provide a detailed review of venoocclusive disease (VOD), Budd-Chiari syndrome (BCS), and congestive hepatopathy (CH), all of which results in hepatic venous outflow obstruction. This is the first article in which all three syndromes have been reviewed, enabling the reader to compare the characteristics of these disorders. The histological findings in VOD, BCS, and CH are almost identical: sinusoidal congestion and cell necrosis mostly in perivenular areas of hepatic acini which eventually leads to bridging fibrosis between adjacent central veins. Tender hepatomegaly with jaundice and ascites is common to all three conditions. However, the clinical presentation depends mostly on the extent and rapidity of the outflow obstruction. Although the etiology and treatment are completely different in VOD, BCS, and CH; the similarities in clinical manifestations and liver histology may suggest a common mechanism of hepatic injury and adaptation in response to increased sinusoidal pressure.

show abstract

Section: Constrictive Pericarditis (Cp)mentioning

confidence: 99%

Hepatic venous outflow obstruction: Three similar syndromes

Bayraktar

Seren²,

Bayraktar³

2007

WJG

116

110

View full text Add to dashboard Cite

show abstract

“…En países desarrollados predominan la cardiocirugía y la radioterapia 9,13,14 . El manejo médico es sólo sintomático, siendo tratamiento definitivo la pericardiectomía 15 , cirugía no exenta de morbilidad.…”

Section: Discussionunclassified

Pericarditis constrictiva como presentación grave e infrecuente de lupus eritematoso sistémico: reporte de un caso y revisión de la literatura

Lustig

Florenzano

Sanhueza³

et al. 2014

Rev. méd. Chile

View full text Add to dashboard Cite

“…In the developing world, tuberculous pericarditis is likely the most common cause of pericardial effusion and constrictive pericarditis 55,56 ; however, in high-income nations, it is rare. 57 Patients can present with pericardial effusion, constrictive pericarditis, or a mixed effusive and constrictive condition. 58 Symptoms are those of effusion or constriction from any cause (dyspnea, cough, orthopnea, edema) in the context of systemic symptoms (night sweats, low-grade fevers, weight loss).…”

Section: Pulmonary Tbmentioning

confidence: 99%

Current Concepts in the Management of Tuberculosis

Sia

Wieland

2011

Mayo Clinic Proceedings

159

108

View full text Add to dashboard Cite

E ffective medical therapy for tuberculosis (TB) has existed for more than half a century, yet TB remains among the most pressing public health issues of our day. Tuberculosis is, in part, a disease of poverty. 1 The fact that it remains the eighth leading cause of death in the world speaks to the challenges facing practitioners and public health officials as they try to control a disease that is so entwined in the cultural and economic fabric of society. Challenges to effective solutions include lack of access to diagnosis and treatment, the frequent coexistence of epidemics of TB and human immunodeficiency virus (HIV), and the Tuberculosis (TB) poses a serious threat to public health throughout the world but disproportionately afflicts low-income nations. Persons in close contact with a patient with active pulmonary TB and those from endemic regions of the world are at highest risk of primary infection, whereas patients with compromised immune systems are at highest risk of reactivation of latent TB infection (LTBI). Tuberculosis can affect any organ system. Clinical manifestations vary accordingly but often include fever, night sweats, and weight loss. Positive results on either a tuberculin skin test or an interferon-γ release assay in the absence of active TB establish a diagnosis of LTBI. A combination of epidemiological, clinical, radiographic, microbiological, and histopathologic features is used to establish the diagnosis of active TB. Patients with suspected active pulmonary TB should submit 3 sputum specimens for acidfast bacilli smears and culture, with nucleic acid amplification testing performed on at least 1 specimen. For patients with LTBI, treatment with isoniazid for 9 months is preferred. Patients with active TB should be treated with multiple agents to achieve bacterial clearance, to reduce the risk of transmission, and to prevent the emergence of drug resistance. Directly observed therapy is recommended for the treatment of active TB. Health care professionals should collaborate, when possible, with local and state public health departments to care for patients with TB. Patients with drug-resistant TB or coinfection with human immunodeficiency virus should be treated in collaboration with TB specialists. Public health measures to prevent the spread of TB include appropriate respiratory isolation of patients with active pulmonary TB, contact investigation, and reduction of the LTBI burden. Proc. 2011;86(4):348-361 AFB = acid-fast bacilli; BCG = bacille Calmette-Guérin; CFP-10 = culture filtrate protein 10; DOT = directly observed therapy; EMB = ethambutol; ESAT-6 = early-secreted antigenic target 6; HIV = human immuno deficiency virus; IFN-γ = interferon-γ; IGRA = IFN-γ release assay; INH = isoniazid; LTBI = latent TBI; MDR-TB = multidrug-resistant TB; NAA = nucleic acid amplification; PZA = pyrazinamide; RIF = rifampin; TB = tuberculosis; TBI = TB infection; TST = tuberculin skin test; XDR-TB = extensively drug-resistant TB Mayo Clin

show abstract

The etiologic spectrum of constrictive pericarditis

Cited by 221 publications

References 28 publications

Hepatic venous outflow obstruction: Three similar syndromes

Hepatic venous outflow obstruction: Three similar syndromes

Pericarditis constrictiva como presentación grave e infrecuente de lupus eritematoso sistémico: reporte de un caso y revisión de la literatura

Current Concepts in the Management of Tuberculosis

Contact Info

Product

Resources

About